Mereo BioPharma Group plc (NASDAQ:MREO) Receives $7.83 Consensus PT from Brokerages
Shares of Mereo BioPharma Group plc (NASDAQ:MREO – Get Free Report) have been given an average rating of “Buy” by the seven research firms that are presently covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a buy rating and three have given a strong buy rating to the company. […]
More Stories
Revance Therapeutics (NASDAQ:RVNC) Research Coverage Started at StockNews.com
StockNews.com began coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report report published on Sunday....
OptimumBank (NASDAQ:OPHC) Research Coverage Started at StockNews.com
StockNews.com initiated coverage on shares of OptimumBank (NASDAQ:OPHC – Free Report) in a research note published on Sunday morning. The...
Ayala Pharmaceuticals (NASDAQ:ADXS) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a report released on Sunday morning. The...
Avinger (NASDAQ:AVGR) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR – Free Report) in a report published on Sunday morning. The firm...
AppFolio (NASDAQ:APPF) Rating Lowered to Neutral at Piper Sandler
AppFolio (NASDAQ:APPF – Get Free Report) was downgraded by equities research analysts at Piper Sandler from an “overweight” rating to...
Ricky Sandler Sells 915,603 Shares of Entain Plc (LON:ENT) Stock
Entain Plc (LON:ENT – Get Free Report) insider Ricky Sandler sold 915,603 shares of the business’s stock in a transaction...